Search Results - "Cheah, C.Y."

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes by Cheah, C.Y., Chihara, D., Romaguera, J.E., Fowler, N.H., Seymour, J.F., Hagemeister, F.B., Champlin, R.E., Wang, M.L.

“…Although ibrutinib is highly effective in patients with relapsed/refractory mantle cell lymphoma (MCL), a substantial proportion of patients have resistant…”
Get full text

Breakthrough therapies in B-cell non-Hodgkin lymphoma by Cheah, C.Y., Fowler, N.H., Wang, M.L.

“…The last 5 years have seen significant advances in our understanding of the molecular pathogenesis of B-cell lymphomas. This has led to the emergence of a…”
Get full text

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes by Cheah, C.Y., Chihara, D., Horowitz, S., Sevin, A., Oki, Y., Zhou, S., Fowler, N.H., Romaguera, J.E., Turturro, F., Hagemeister, F.B., Fayad, L.E., Wang, M., Neelapu, S.S., Nastoupil, L.J., Westin, J.R., Rodriguez, M.A., Samaniego, F., Anderlini, P., Nieto, Y., Fanale, M.A.

“…Brentuximab vedotin (BV) is a key therapeutic agent for patients with relapsed/refractory classical Hodgkin lymphoma (cHL). The outcomes of patients…”
Get full text

Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era by Cheah, C.Y., Chihara, D., Ahmed, M., Davis, R.E., Nastoupil, L.J., Phansalkar, K., Hagemeister, F.B., Fayad, L.E., Westin, J.R., Oki, Y., Fanale, M.A., Romaguera, J.E., Wang, M.L., Lee, H., Turturro, F., Samaniego, F., Rodriguez, M.A., Neelapu, S.S., Fowler, N.H.

“…The optimal initial therapy of follicular lymphoma (FL) remains unclear. The aims of this study were to compare primary treatment strategies and assess the…”
Get full text

SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL by Verner, E.K., Johnston, A.J., Pati, N., Hawkes, E., Lee, H., Cochrane, T., Cheah, C.Y., Filshie, R., Purtill, D., Enjeti, A.K., Brown, C., Murphy, N., Curnow, J., Cake, S., Carlson, J., Butcher, B.E., Trotman, J.

Get full text

UMBRALISIB MONOTHERAPY DEMONSTRATES EFFICACY AND SAFETY IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA: A MULTICENTER, OPEN‐LABEL, REGISTRATION DIRECTED PHASE 2 STUDY by Zinzani, P., Samaniego, F., Jurczak, W., Lech‐Maranda, E., Ghosh, N., Anz, B., Patten, P., Reeves, J., Leslie, L.A., Smolewski, P., Chavez, J.C., Scarfo, L., Derenzini, E., Burke, J.M., Sharman, J., Kolibaba, K., O'Connor, O.A., Cheah, C.Y., Miskin, H.P., Sportelli, P., Weiss, M.S., Fowler, N.H.

Get full text

CLINICAL OUTCOMES FROM VENETOCLAX BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMAS by Lewis, K.L., Dowling, M., Bavishi, K., Øvlisen, A.K., Hamad, N., Choi, P., Grigg, A., P'Ng, S., Filshie, R., Ritchie, D.S., Bilmon, I., Prince, H.M., Wolf, M., Hertzberg, M., Chuah, H., El‐Galaly, T.C., Tam, C.S., Seymour, J.F., Cheah, C.Y.

Get full text

Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network by Cheah, C.Y., George, A., Giné, E., Chiappella, A., Kluin-Nelemans, H.C., Jurczak, W., Krawczyk, K., Mocikova, H., Klener, P., Salek, D., Walewski, J., Szymczyk, M., Smolej, L., Auer, R.L., Ritchie, D.S., Arcaini, L., Williams, M.E., Dreyling, M., Seymour, J.F.

“…Central nervous system (CNS) involvement in mantle cell lymphoma (MCL) is uncommon, and the manifestations and natural history are not well described. We…”
Get full text

PS1068 SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMA by Verner, E., Johnston, A., Pati, N., Hawkes, E., Lee, H.P., Cochrane, T., Cheah, C.Y., Filshie, R., Purtill, D., Sia, H., Enjeti, A.K., Brown, C., Murphy, N., Curnow, J., Cake, S., Carlson, J., Butcher, B., Trotman, J.

“…Background: A significant proportion, ∼40% of patients with Diffuse Large B Cell Lymphoma (DLBCL) are ≥70years (yrs). With a rapidly rising aging population,…”
Get full text

Spreading and evaporation of sessile droplets: Universal behaviour in the case of complete wetting by Lee, K.S., Cheah, C.Y., Copleston, R.J., Starov, V.M., Sefiane, K.

“…Experiments on spreading and evaporation of sessile droplets on a solid substrate under various conditions are reported and compared to the developed…”
Get full text

FREQUENCY OF PERFORATION & IMPACT OF BOWEL REST IN AGGRESSIVE NON‐HODGKIN LYMPHOMA WITH GASTROINTESTINAL INVOLVEMENT: AN INTERNATIONAL, MULTI‐CENTER RETROSPECTIVE STUDY by Chin, C.K., Tsang, E., Mediwake, H., Khair, W., Biccler, J.L., El‐Galaly, T.C., Hapgood, G., Mollee, P., Villa, D., Nizich, Z., Joske, D., Radeski, D., Cull, G., Cheah, C.Y.

Get full text

SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL by Verner, E.K., Johnston, A.J., Pati, N., Hawkes, E., Lee, H., Cochrane, T., Cheah, C.Y., Filshie, R., Purtill, D., Enjeti, A.K., Brown, C., Murphy, N., Curnow, J., Cake, S., Carlson, J., Butcher, B.E., Trotman, J.

Get full text

UMBRALISIB MONOTHERAPY DEMONSTRATES EFFICACY AND SAFETY IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA: A MULTICENTER, OPEN‐LABEL, REGISTRATION DIRECTED PHASE 2 STUDY by Zinzani, P., Samaniego, F., Jurczak, W., Lech‐Maranda, E., Ghosh, N., Anz, B., Patten, P., Reeves, J., Leslie, L.A., Smolewski, P., Chavez, J.C., Scarfo, L., Derenzini, E., Burke, J.M., Sharman, J., Kolibaba, K., O'Connor, O.A., Cheah, C.Y., Miskin, H.P., Sportelli, P., Weiss, M.S., Fowler, N.H.

Get full text